Since Chile’s Economic and Environmental Crimes Act (Law No. 21.595) came into effect, amending Law No. 20.393 on the criminal liability of ...

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

This cell-like structure can grow, feed, divide and compete. Researchers ponder what it means for the future of synthetic ...

Bocunebart's PACAP-targeting mechanism positions it as a potential first-in-class therapy in a thin pipeline of novel ...

LLVM powers the core development tools, operating systems, and most applications at Apple Computer, where it long ago ...

Annual Awards Program Recognizes Innovation in the Global Supply Chain Technology and Logistics Industry LOS ANGELES, July 01, 2026 (GLOBE NEWSWIRE) -- SupplyTech Breakthrough, a leading independent ...

Here is a closer look at student self-governance organizations at the University, beginning with the organization that ...

Reasons to be Cheerful reports that cycling improves focus in kids, especially those with ADHD, as seen in Spooner Middle ...

Scientists say they have built a cell from scratch for the first time that can feed, grow and replicate like a natural cell.

The F-22 is a highly capable aircraft, however the F-35 has begun to leave it behind in several critical areas.

Forward Industries must address its mandate, corporate governance, capital allocation discipline, related-party structure, ...

Taysha Gene Therapies (TSHA) remains a Buy on strong TSHA-102 Rett data, FDA-aligned pivotal path, and cash to 2028—read the ...